The effect of these suramin derivatives on PrPSc was determined in prion-infected neuroblastoma cells (3F4-ScN2a) using a solubility assay and proteinase K (PK) treatment followed by immunoblot analysis. This evidence concerns the gene SCN2A and neuroblastoma.